Abbott India Ltd.

Research Abbott India Ltd. (ABBOTINDIA.NS) on Bullrun: market cap INR 556.09B, P/E 34.4, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is INR 556.09B; P/E is 34.4; dividend yield is 2.5%.

Peer valuation comparison

Latest P/E is 34.44x versus a Healthcare sector median of 21.74x (58.4% above).

Latest dividend yield is 2.51% versus a Healthcare sector median of 2.4% (4.6% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18INR 556.09B34.42.0%525

Dividend history

Latest trailing dividend snapshot: annual dividend/share 525 INR, yield 2.5%.

About Abbott India Ltd.

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Abbott India Ltd.'s market cap?

Abbott India Ltd.'s market capitalization is INR 556.09B.

What is Abbott India Ltd.'s P/E ratio?

Abbott India Ltd.'s price-to-earnings (P/E) ratio is 34.4.

Does Abbott India Ltd. pay a dividend?

Abbott India Ltd. has a dividend yield of 2.5%.

What does Abbott India Ltd. do?

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products.